10-15 Associates’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,955
Closed -$76K 99
2019
Q2
$76K Sell
2,955
-310
-9% -$9.67K 0.02% 98
2019
Q1
$118K Sell
3,265
-650
-17% -$22.3K 0.03% 96
2018
Q4
$113K Sell
3,915
-565
-13% -$24.4K 0.03% 89
2018
Q3
$294K Sell
4,480
-655
-13% -$42.5K 0.07% 90
2018
Q2
$335K Sell
5,135
-35
-0.7% -$2.19K 0.08% 92
2018
Q1
$284K Sell
5,170
-240
-4% -$14.2K 0.07% 91
2017
Q4
$361K Sell
5,410
-520
-9% -$30.7K 0.09% 84
2017
Q3
$349K Sell
5,930
-215
-3% -$10.5K 0.09% 78
2017
Q2
$270K Sell
6,145
-75
-1% -$3.89K 0.08% 80
2017
Q1
$364K Buy
6,220
+205
+3% +$12.3K 0.1% 78
2016
Q4
$353K Sell
6,015
-440
-7% -$25.1K 0.1% 84
2016
Q3
$338K Sell
6,455
-85
-1% -$3.81K 0.09% 92
2016
Q2
$255K Buy
6,540
+370
+6% +$13.6K 0.07% 99
2016
Q1
$187K Sell
6,170
-419
-6% -$9.64K 0.06% 103
2015
Q4
$168K Sell
6,589
-85
-1% -$3.11K 0.05% 115
2015
Q3
$214K Sell
6,674
-311
-4% -$11.9K 0.07% 99
2015
Q2
$384K Sell
6,985
-295
-4% -$18.8K 0.12% 89
2015
Q1
$405K Hold
7,280
0.14% 91
2014
Q4
$504K Sell
7,280
-969
-12% -$82.5K 0.16% 83
2014
Q3
$874K Buy
8,249
+104
+1% +$11.5K 0.29% 65
2014
Q2
$965K Sell
8,145
-245
-3% -$28.4K 0.31% 61
2014
Q1
$896K Buy
8,390
+60
+0.7% +$5.68K 0.29% 62
2013
Q4
$751K Buy
8,330
+455
+6% +$41.5K 0.26% 64
2013
Q3
$682K Sell
7,875
-10
-0.1% -$871 0.28% 58
2013
Q2
$668K Buy
+7,885
New +$730K 0.31% 55

Other funds holding OVV

10-15 Associates's OVV Position: Q3 2019 in Review

10-15 Associates sold out of Ovintiv (OVV) in Q3 2019, closing a stake of 2,955 shares — an estimated $76K sold.

10-15 Associates first reported a position in OVV in Q2 2013 and held it in 25 quarters. The position peaked at $965K in Q2 2014. 420 funds tracked by Wall St. Rank hold OVV as of Q3 2019.

  • 10-15 Associates reported no remaining Ovintiv position as of Q3 2019 after selling out during the quarter.
  • 10-15 Associates sold 2,955 Ovintiv shares in Q3 2019, an estimated $76K.
  • 10-15 Associates first reported a position in Ovintiv in Q2 2013 and held it in 25 quarters.
  • 10-15 Associates's Ovintiv position peaked at $965K in Q2 2014.
  • 420 funds tracked by Wall St. Rank held Ovintiv as of Q3 2019.

Based on 10-15 Associates's 13F filing for Q3 2019, filed 12 Nov 2019.